TTOO Operating Income vs Interest Expense Analysis

TTOO Stock  USD 3.00  0.05  1.64%   
T2 Biosystms financial indicator trend analysis is much more than just breaking down T2 Biosystms prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether T2 Biosystms is a good investment. Please check the relationship between T2 Biosystms Operating Income and its Interest Expense accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in T2 Biosystms. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.

Operating Income vs Interest Expense

Operating Income vs Interest Expense Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of T2 Biosystms Operating Income account and Interest Expense. At this time, the significance of the direction appears to have pay attention.
The correlation between T2 Biosystms' Operating Income and Interest Expense is -0.87. Overlapping area represents the amount of variation of Operating Income that can explain the historical movement of Interest Expense in the same time period over historical financial statements of T2 Biosystms, assuming nothing else is changed. The correlation between historical values of T2 Biosystms' Operating Income and Interest Expense is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Operating Income of T2 Biosystms are associated (or correlated) with its Interest Expense. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Interest Expense has no effect on the direction of Operating Income i.e., T2 Biosystms' Operating Income and Interest Expense go up and down completely randomly.

Correlation Coefficient

-0.87
Relationship DirectionNegative 
Relationship StrengthSignificant

Operating Income

Operating Income is the amount of profit realized from T2 Biosystms operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of T2 Biosystms is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Interest Expense

The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.
Most indicators from T2 Biosystms' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into T2 Biosystms current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in T2 Biosystms. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.As of the 28th of March 2024, Selling General Administrative is likely to drop to about 26 M. In addition to that, Issuance Of Capital Stock is likely to drop to about 45 M
 2021 2022 2023 2024 (projected)
Interest Expense6.6M6.1M5.7M5.0M
Depreciation And Amortization318K39K35.1K33.3K

T2 Biosystms fundamental ratios Correlations

0.450.260.110.880.160.55-0.24-0.240.10.750.550.370.170.40.840.240.050.17-0.450.330.35-0.60.550.90.01
0.450.810.370.340.650.950.63-0.920.54-0.040.89-0.30.620.870.050.820.040.37-0.380.90.99-0.260.950.20.21
0.260.810.780.240.270.680.54-0.780.7-0.070.58-0.230.330.7-0.040.540.460.56-0.650.630.8-0.280.680.080.64
0.110.370.780.18-0.220.230.2-0.340.380.060.120.05-0.150.220.020.050.810.57-0.780.090.35-0.270.230.070.96
0.880.340.240.18-0.150.4-0.42-0.050.010.830.370.51-0.040.30.89-0.010.290.18-0.650.180.23-0.80.40.920.16
0.160.650.27-0.22-0.150.650.78-0.790.31-0.440.7-0.590.860.57-0.330.95-0.63-0.030.240.790.690.110.65-0.21-0.41
0.550.950.680.230.40.650.54-0.830.520.050.95-0.140.550.810.160.77-0.020.26-0.290.820.92-0.241.00.30.06
-0.240.630.540.2-0.420.780.54-0.830.54-0.780.56-0.650.640.54-0.70.85-0.220.260.050.690.70.220.54-0.580.02
-0.24-0.92-0.78-0.34-0.05-0.79-0.83-0.83-0.610.33-0.80.54-0.73-0.820.24-0.930.1-0.370.23-0.9-0.950.06-0.830.08-0.15
0.10.540.70.380.010.310.520.54-0.61-0.290.51-0.170.270.61-0.190.490.130.59-0.20.590.560.040.52-0.070.23
0.75-0.04-0.070.060.83-0.440.05-0.780.33-0.29-0.040.56-0.26-0.030.96-0.390.29-0.1-0.42-0.21-0.15-0.560.050.920.11
0.550.890.580.120.370.70.950.56-0.80.51-0.04-0.030.480.760.140.79-0.160.38-0.180.830.87-0.170.950.28-0.03
0.37-0.3-0.230.050.51-0.59-0.14-0.650.54-0.170.56-0.03-0.77-0.330.64-0.580.350.22-0.2-0.44-0.37-0.21-0.140.590.18
0.170.620.33-0.15-0.040.860.550.64-0.730.27-0.260.48-0.770.54-0.250.86-0.54-0.230.040.740.63-0.140.55-0.14-0.36
0.40.870.70.220.30.570.810.54-0.820.61-0.030.76-0.330.540.050.730.030.5-0.270.860.88-0.210.810.20.07
0.840.05-0.040.020.89-0.330.16-0.70.24-0.190.960.140.64-0.250.05-0.280.20.04-0.38-0.08-0.05-0.540.160.990.06
0.240.820.540.05-0.010.950.770.85-0.930.49-0.390.79-0.580.860.73-0.28-0.410.18-0.030.890.84-0.040.77-0.13-0.17
0.050.040.460.810.29-0.63-0.02-0.220.10.130.29-0.160.35-0.540.030.2-0.410.44-0.75-0.290.0-0.37-0.020.180.87
0.170.370.560.570.18-0.030.260.26-0.370.59-0.10.380.22-0.230.50.040.180.44-0.380.360.39-0.030.260.140.56
-0.45-0.38-0.65-0.78-0.650.24-0.290.050.23-0.2-0.42-0.18-0.20.04-0.27-0.38-0.03-0.75-0.38-0.1-0.310.81-0.29-0.42-0.72
0.330.90.630.090.180.790.820.69-0.90.59-0.210.83-0.440.740.86-0.080.89-0.290.36-0.10.92-0.090.820.08-0.07
0.350.990.80.350.230.690.920.7-0.950.56-0.150.87-0.370.630.88-0.050.840.00.39-0.310.92-0.160.920.10.19
-0.6-0.26-0.28-0.27-0.80.11-0.240.220.060.04-0.56-0.17-0.21-0.14-0.21-0.54-0.04-0.37-0.030.81-0.09-0.16-0.24-0.55-0.2
0.550.950.680.230.40.651.00.54-0.830.520.050.95-0.140.550.810.160.77-0.020.26-0.290.820.92-0.240.30.06
0.90.20.080.070.92-0.210.3-0.580.08-0.070.920.280.59-0.140.20.99-0.130.180.14-0.420.080.1-0.550.30.08
0.010.210.640.960.16-0.410.060.02-0.150.230.11-0.030.18-0.360.070.06-0.170.870.56-0.72-0.070.19-0.20.060.08
Click cells to compare fundamentals

T2 Biosystms Account Relationship Matchups

T2 Biosystms fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets28.5M79.1M60.5M34.4M39.5M62.0M
Short Long Term Debt Total44.8M55.8M57.1M59.2M68.1M40.9M
Other Current Liab13.6M6.4M7.2M7.7M8.8M6.6M
Total Current Liabilities60.6M9.8M11.7M10.5M12.1M23.0M
Total Stockholder Equity(34.0M)8.7M(12.9M)(40.0M)(46.0M)(43.7M)
Other Liab46K4.8M4.6M4.9M5.6M5.9M
Property Plant And Equipment Net9.2M14.8M14.4M13.3M15.3M9.8M
Net Debt33.7M39.0M34.9M48.9M56.2M59.0M
Retained Earnings(376.2M)(423.0M)(472.2M)(534.5M)(481.1M)(457.0M)
Accounts Payable3.8M2.1M2.8M1.3M1.5M1.6M
Cash11.0M16.8M22.2M10.3M9.3M8.8M
Non Current Assets Total9.6M25.5M16.1M15.0M17.2M11.7M
Cash And Short Term Investments11.0M42.2M32.2M10.3M9.3M8.8M
Common Stock Total Equity36K44K51K147K169.1K177.5K
Common Stock Shares Outstanding455.1K24.3K31.8K51.0K58.7K55.7K
Liabilities And Stockholders Equity28.5M79.1M60.5M34.4M39.5M62.0M
Non Current Liabilities Total1.9M60.6M61.8M63.9M57.5M34.1M
Other Current Assets1.4M2.7M3.1M2.6M3.0M1.5M
Other Stockholder Equity342.1M431.5M459.2M494.6M568.7M288.0M
Total Liab62.5M70.4M73.4M74.4M66.9M50.8M
Property Plant And Equipment Gross9.2M14.8M14.4M13.3M15.3M9.8M
Total Current Assets18.9M53.6M44.4M19.4M17.5M16.6M
Accumulated Other Comprehensive Income(11.3M)(13.2M)9K(4K)(3.6K)(3.8K)
Short Term Debt42.9M1.2M1.2M1.4M1.6M1.5M
Common Stock49K147K166K8K9.2K8.7K
Property Plant Equipment5.8M14.8M14.4M13.3M15.3M9.5M
Net Tangible Assets(32.1M)8.7M(12.9M)(40.0M)(36.0M)(34.2M)
Current Deferred Revenue285K230K518K172K154.8K147.1K
Net Receivables2.8M5.1M5.1M2.2M2.5M2.2M
Retained Earnings Total Equity(266.1M)(317.2M)(376.2M)(423.0M)(380.7M)(399.7M)
Capital Surpluse267.4M328.5M342.1M431.5M496.3M308.8M
Inventory3.6M3.6M3.9M4.3M5.0M2.6M
Capital Lease Obligations3.9M10.5M9.4M9.6M11.0M5.7M
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards T2 Biosystms in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, T2 Biosystms' short interest history, or implied volatility extrapolated from T2 Biosystms options trading.

Currently Active Assets on Macroaxis

When determining whether T2 Biosystms offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of T2 Biosystms' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of T2 Biosystms Stock. Outlined below are crucial reports that will aid in making a well-informed decision on T2 Biosystms Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in T2 Biosystms. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Complementary Tools for TTOO Stock analysis

When running T2 Biosystms' price analysis, check to measure T2 Biosystms' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy T2 Biosystms is operating at the current time. Most of T2 Biosystms' value examination focuses on studying past and present price action to predict the probability of T2 Biosystms' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move T2 Biosystms' price. Additionally, you may evaluate how the addition of T2 Biosystms to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Stocks Directory
Find actively traded stocks across global markets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Fundamental Analysis
View fundamental data based on most recent published financial statements
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Is T2 Biosystms' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of T2 Biosystms. If investors know TTOO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about T2 Biosystms listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(35.62)
Revenue Per Share
7.933
Quarterly Revenue Growth
(0.60)
Return On Assets
(0.68)
Return On Equity
(6.22)
The market value of T2 Biosystms is measured differently than its book value, which is the value of TTOO that is recorded on the company's balance sheet. Investors also form their own opinion of T2 Biosystms' value that differs from its market value or its book value, called intrinsic value, which is T2 Biosystms' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because T2 Biosystms' market value can be influenced by many factors that don't directly affect T2 Biosystms' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between T2 Biosystms' value and its price as these two are different measures arrived at by different means. Investors typically determine if T2 Biosystms is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, T2 Biosystms' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.